ABBVIE

World Rank (Jul-30-2023)
33
Market Cap (Jul-30-2023)
266.14 Billion USD
World Rank (Dec-25-2022)
29
Market Cap (Dec-25-2022)
288.44 Billion USD
World Rank (Jan-07-2022)
46
Market Cap (Jan-07-2022)
238.450 Billion USD
World Rank (Jan-01-2021)
51
Market Cap (Jan-01-2021)
189.100 Billion USD
Annual Revenue in USD
58,054 Million USD
Annual Net Income in USD
11,782 Million USD
Total Assets in USD
138,800 Million USD
Total Liabilities in USD
121,520 Million USD
Annual Results for Year ending in
Dec-2022 month
Headquarters State / City
Illinois
Headquarters Country
USA
Headquarters Sub Region
Northern America
Headquarters Continent
Americas
Company Business
Healthcare
Pharmaceutical
Biotechnology
HealthCare Products
Healthcare Service
Stock Category
S&P 500
Stock Exchange
NYSE
Company Rank in Country in 2022
Company Rank in USA in 2022 is 32
Rank in Country (Jan-2021)
Company Rank in USA in 2021 is 34
Rank in Country (Jan-2020)
Rank in USA in 2020 is 43
Number of Employees
50,000
Employee Count as on Date
As on Jan-2023
CEO:
Richard A. Gonzalez
Yahoo @ NYSE
Wikipedia
Facebook
Company Website:
Abbvie - Healthcare and Bio-Pharmaceutical Company
Business Sector:
Top Technology Companies in USA
Top Healthcare Companies in USA
Top Technology Companies in S&P 500
Top Healthcare Companies in S&P 500
Top Pharmaceutical Companies in USA
Top Pharmaceutical Companies in S&P 500
About Company Business:

Abbvie is USA based healthcare and pharmaceutical multi-national company that takes on the toughest health challenges. Abbvie do more than treat diseases and they aim to make a remarkable impact on people’s lives. AbbVie is highly focus research-driven bio-pharmaceutical company. Headquarters is in USA.

Facts About Company

As on 2023, Abbvie has 50,000 employees.

Abbvie annual revenue generated for period ending Dec-2022 was 58,054  million USD.

Abbvie annual net income generated for period ending Dec-2022 was 11,782 million USD.

As on 2020, Abbvie has 47,000 employees who are scientists, researchers, communicators, manufacturing specialists and regulatory experts located around the globe.

Abbvie  annual revenue generated for period ending Dec-2021 was 56,197 million USD.

Abbvie annual net income generated for period ending Dec-2021 was 11,542 million USD.

Total Assets as on Dec-2021 was 146,529 Million USD.

IPO Year
2012
Founded Year
2013
Annual Results Summary:

Abbvie Inc - Yearly Revenue and Net Profit - in Million USD:

Year - Ending Revenue Net Profit
Dec-2022 58,054 11,782
Dec-2021 56,197 11,542
Dec-2020 45,804 4,616
Dec-2019 33,266 7,882
Dec-2018 33,753 5,687
Dec-2017 28,216 5,309
Dec-2016 25,638 5,953
Balance Sheet Summary

Abbvie Inc - Balance Sheet Summary - in Million USD:

Year Ending: Total Assets Total Liabilities Total Equity
Dec-2022 138,805 121,518 17,287
Dec-2021 146,529 131,121 15,408
Dec-2020 150,565 137,489 13,076
Dec-2019 89,115 97,287 (8,172)
Dec-2018 59,352 67,798 (8,446)
Dec-2017 70,786 65,689 5,097
Dec-2016 66,099 61,463 4,636
Quarterly Results Summary:

Abbvie Inc - Quarterly Revenue and Net Profit - in Million USD:

Quarter - Ending Revenue Net Profit
Jun-2023 13,865 2,024
Mar-2023 12,225 239
Dec-2022 15,121 2,462
Sep-2022 14,812 3,931
Jun-2022 14.583 913
Mar-2022 13,538 4,468
Dec-2021 14,886 4,044
Sep-2021 14,342 3,158
Jun-2021 13,959 766
Mar-2021 13,010 3,553
Dec-2020 13,858 36
Sep-2020 12,902 2,308
Jun-2020 10,425 -738
Mar-2020 8,619 3,010
Dec-2019 8,704 2,801
Sep-2019 8,479 1,874
Jun-2019 8,255   741
Mar-2019 7,828 2,456
Dec-2018 8,305 -1,826
Sep-2018 8,236 2,747
Institutional Investors

Top 30 Institutional Investors in ABBVIE as on MAR-31-2023

RANK Institutional Investors DATE SHARES HELD CHANGE (SHARES) CHANGE (%) VALUE (IN 1,000S)
1 VANGUARD GROUP INC 3/31/2023 160,466,347 2,148,795 1.36% $24,193,511
2 BLACKROCK INC. 3/31/2023 138,721,510 18,752 0.01% $20,915,042
3 STATE STREET CORP 3/31/2023 77,026,437 -1,042,817 -1.34% $11,613,276
4 JPMORGAN CHASE & CO 3/31/2023 57,898,564 -3,011,650 -4.94% $8,729,366
5 CAPITAL INTERNATIONAL INVESTORS 3/31/2023 42,748,362 -4,350,245 -9.24% $6,445,171
6 CAPITAL RESEARCH GLOBAL INVESTORS 3/31/2023 35,714,367 -997,422 -2.72% $5,384,655
7 GEODE CAPITAL MANAGEMENT, LLC 3/31/2023 34,045,021 292,512 0.87% $5,132,968
8 MORGAN STANLEY 3/31/2023 31,427,994 -143,756 -0.46% $4,738,399
9 NORTHERN TRUST CORP 3/31/2023 22,225,004 268,579 1.22% $3,350,864
10 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 3/31/2023 21,536,656 12,515,744 138.74% $3,247,082
11 BANK OF AMERICA CORP /DE/ 3/31/2023 20,707,852 726,693 3.64% $3,122,123
12 BANK OF NEW YORK MELLON CORP 6/30/2023 20,003,255 -184,804 -0.92% $3,015,891
13 NORGES BANK 12/31/2022 18,769,556 1,035,188 5.84% $2,829,886
14 PRICE T ROWE ASSOCIATES INC /MD/ 3/31/2023 17,575,880 -2,847,220 -13.94% $2,649,915
15 AMERIPRISE FINANCIAL INC 3/31/2023 14,717,788 1,463,681 11.04% $2,219,001
16 JANUS HENDERSON GROUP PLC 3/31/2023 13,494,736 -2,029,836 -13.08% $2,034,601
17 FMR LLC 3/31/2023 12,885,486 -1,478,010 -10.29% $1,942,745
18 LEGAL & GENERAL GROUP PLC 3/31/2023 11,886,553 148,488 1.27% $1,792,136
19 NUVEEN ASSET MANAGEMENT, LLC 3/31/2023 11,376,099 -977,479 -7.91% $1,715,174
20 UBS GROUP AG 3/31/2023 10,897,239 88,432 0.82% $1,642,977
21 GOLDMAN SACHS GROUP INC 3/31/2023 10,119,454 1,282,296 14.51% $1,525,710
22 UBS ASSET MANAGEMENT AMERICAS INC 3/31/2023 9,983,369 -786,314 -7.30% $1,505,193
23 WELLS FARGO & COMPANY/MN 3/31/2023 9,767,684 -95,631 -0.97% $1,472,674
24 ROYAL BANK OF CANADA 3/31/2023 9,710,813 -65,354 -0.67% $1,464,099
25 AMUNDI 3/31/2023 8,652,207 2,494,894 40.52% $1,304,493
26 INVESCO LTD. 3/31/2023 8,095,258 -902,953 -10.04% $1,220,522
27 FRANKLIN RESOURCES INC 3/31/2023 8,082,959 -2,736,893 -25.30% $1,218,668
28 DIMENSIONAL FUND ADVISORS LP 6/30/2023 7,732,933 157,871 2.08% $1,165,894
29 T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 3/31/2023 7,597,503 4,317,571 131.64% $1,145,476
30 STATE FARM MUTUAL AUTOMOBILE INSURANCE CO 3/31/2023 6,513,917 -932,312 -12.52% $982,103

Share it on Social Media